FDA Approves US Trial of Cuban Lung Cancer Vaccine

Portal Forums Cancer Treatments / Symptom Management Other Novel Therapies FDA Approves US Trial of Cuban Lung Cancer Vaccine

This topic contains 1 reply, has 2 voices, and was last updated by JimC Forum Moderator JimC Forum Moderator 1 year, 8 months ago.

Viewing 2 posts - 1 through 2 (of 2 total)
Author Posts   
Author Posts
October 29, 2016 at 3:44 pm  #1289024    


The CimaVax vaccine was developed for NSCLC and it targets the EGFR overexpression. My daughters tumor tested negative for EGFR mutations. What effect does it have for EGFR positive mutations? Is the EGFR mutation even related to the vaccine? The article posted on Medscape says it targets EGFR overexpression found on approximately 40% to 80% of NSCLC. So how does one know if their cancer overexpresses EGFR and how much?

October 30, 2016 at 9:14 am  #1289027    
JimC Forum Moderator
JimC Forum Moderator

Hi fanos,

The CimaVax vaccine is not specifically directed at tumors with activating EGFR mutations. EGFR overexpression can be tested by staining the tumor tissue using a process known as immunohistochemistry (IHC).

Though this vaccine has shown promise in trials performed in Cuba, many experts in the rest of the world are waiting for more concrete proof of its efficacy, and trials in the U.S. and other locations are just beginning, so it may be some time before we have convincing evidence.

Forum moderator

Jul 2008 Wife Liz (51/never smoker) Dx Stage IV NSCLC EGFR exon 19
4 cycles Carbo/alimta, 65% shrinkage
Tarceva maintenance
Mar 2010 progression, added Alimta, stable
Sep 2010 multiple brain mets, WBR
Oct 2010 large pericardial effusion, tamponade
Jan 2011 progression, start abraxane
Jun 2011-New liver, brain mets, add Tarceva
Oct 2011-Dx Leptomeningeal carcinomatosis; pulsed Tarceva
At rest Nov 4 2011
Since then: http://cancergrace.org/blog/jim-and-lisa

Viewing 2 posts - 1 through 2 (of 2 total)

You must be logged in to reply to this topic.